INTERIM SAFETY-ANALYSIS OF THE AVATACE-1 TRIAL (BEVACIZUMAB AS INHIBITOR OF COLLATERAL TUMOR-VESSEL GROWTH DURING TRANSARTERIAL CHEMOEMBOLISATION (TACE) FOR HEPATOCELLULAR CARCINOMA - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED PILOT-TRIAL

Category Primary study
JournalJOURNAL OF HEPATOLOGY
Year 2010
This article has no abstract
Epistemonikos ID: cef1308e48176868a8c57c9f23c6f741b94a563c
First added on: Feb 28, 2025